4BIO Capital Portfolio Company Trogenix Unveils Revolutionary Platform to Transform Cancer Treatment Through Precision Viral Immunotherapy [Yahoo! Finance]
Zimmer Biomet Holdings, Inc. (ZBH)
Last zimmer biomet holdings, inc. earnings: 2/4 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
investor.zimmerbiomet.com
Company Research
Source: Yahoo! Finance
Company founded by 4BIO Capital and Professor Steve Pollard as a spinout from the University of Edinburgh to commercialise its breakthrough Synthetic Super-Enhancer platform, Odysseus, to enable unprecedented precision in targeting aggressive cancers IQ Capital, Cancer Research Horizons, National Brain Tumor Society, AIN Ventures and Old College Capital now also investors in Trogenix Dr Ken Macnamara, a veteran gene therapy executive who held leadership roles at Bayer/AskBio and Synpromics, appointed as Chief Executive Officer Tay Salimullah, former executive team member at Novartis Gene Therapies, joins the Board as Trogenix advances towards clinical development LONDON, 18 November 2024 – 4BIO Capital (“4BIO” or “the Group”), an international venture capital firm unlocking the treatments of the future by investing in advanced therapies and other emerging technologies, today announces that its portfolio company, Trogenix Ltd, has emerged from stealth mode to unveil its ground
Show less
Read more
Impact Snapshot
Event Time:
ZBH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ZBH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ZBH alerts
High impacting Zimmer Biomet Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
ZBH
News
- Fresenius Kabi Submits 510(k) Notification for the Aurora Xi Plasmapheresis System Software Version 2.0 with New Nomogram [Yahoo! Finance]Yahoo! Finance
- SPR® Therapeutics Debuts New SPRINT® PNS Data for Low Back, Shoulder, Knee, and Headache at the 23rd Annual ASRA Pain Medicine Meeting [Yahoo! Finance]Yahoo! Finance
- Zimmer Biomet to Present at Citi's 2024 Global Healthcare ConferencePR Newswire
- Hexaware Launches QCaaS in Partnership with Archimedis Digital [Yahoo! Finance]Yahoo! Finance
- J&J Loses Around $24B in a Month: How to Play the Stock? [Yahoo! Finance]Yahoo! Finance
ZBH
Earnings
- 10/30/24 - Miss
ZBH
Sec Filings
- 11/20/24 - Form 8-A12B
- 11/20/24 - Form 8-K
- 11/19/24 - Form 8-K
- ZBH's page on the SEC website